Literature DB >> 6542630

Serotonin levels and platelet uptake during premenstrual tension.

D L Taylor, R J Mathew, B T Ho, M L Weinman.   

Abstract

Premenstrual tension was studied in 16 females, using both biochemical and psychological parameters during the pre- and postmenstrual phases. Uptake of serotonin (5-HT) and the levels of 5-HT in platelet-rich plasma and platelet-poor plasmas were determined. Degrees of distress experienced pre- and postmenstrually were quantified via the Moos menstrual distress questionnaire. The mean Vmax was significantly lower during the premenstrual (tension) phase (8.2 +/- 0.9 pmol/min) as compared to the postmenstrual (normal) phase (14.4 +/- 3.2 pmol/min). There was no significant difference in the Km values. A highly significant (p less than 0.001) reduction in the levels of 5-HT in platelet-rich plasma (-23.2%) and platelet-poor plasma (-19.1%) was found during the premenstrual phase. There were correlations between the kinetic parameters of 5-HT uptake and some of the Moos symptoms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542630     DOI: 10.1159/000118103

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  14 in total

Review 1.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Premenstrual syndrome: current knowledge and management.

Authors:  G E Robinson
Journal:  CMAJ       Date:  1989-03-15       Impact factor: 8.262

Review 3.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Sarah Canning; Mitch Waterman; Nic Orsi; Julie Ayres; Nigel Simpson; Louise Dye
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

5.  Sleep, Hormones, and Circadian Rhythms throughout the Menstrual Cycle in Healthy Women and Women with Premenstrual Dysphoric Disorder.

Authors:  Ari Shechter; Diane B Boivin
Journal:  Int J Endocrinol       Date:  2010-01-18       Impact factor: 3.257

6.  Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome.

Authors:  C R Ashby; L A Carr; C L Cook; M M Steptoe; D D Franks
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 7.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.

Authors:  J F Mortola
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

9.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-04-01       Impact factor: 5.590

10.  Serotonin and measured intelligence.

Authors:  E H Cook; B L Leventhal; D X Freedman
Journal:  J Autism Dev Disord       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.